RH5.1-CyRPA-Ripr antigen combination vaccine shows little improvement over RH5.1 in a preclinical setting
<strong>Background: </strong>RH5 is the leading vaccine candidate for the Plasmodium falciparum blood stage and has shown impact on parasite growth in the blood in a human clinical trial. RH5 binds to Ripr and CyRPA at the apical end of the invasive merozoite form, and this complex, desi...
Những tác giả chính: | Healer, J, Thompson, JK, Mackwell, KL, Browne, CD, Seager, BA, Ngo, A, Lowes, KN, Silk, SE, Pulido, D, King, LDW, Christen, JM, Noe, AR, Kotraiah, V, Masendycz, PJ, Rajagopalan, R, Lucas, L, Stanford, MM, Soisson, L, Diggs, C, Miller, R, Youll, S, Wycherley, K, Draper, SJ, Cowman, AF |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
Frontiers Media
2022
|
Những quyển sách tương tự
-
RH5.1-CyRPA-Ripr antigen combination vaccine shows little improvement over RH5.1 in a preclinical setting
Bằng: Julie Healer, et al.
Được phát hành: (2022-12-01) -
The RH5-CyRPA-Ripr complex as a malaria vaccine target
Bằng: Ragotte, RJ, et al.
Được phát hành: (2020) -
Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex
Bằng: Williams, BG, et al.
Được phát hành: (2024) -
Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex
Bằng: Barnabas G. Williams, et al.
Được phát hành: (2024-06-01) -
Divergent roles for the RH5 complex components, CyRPA and RIPR in human-infective malaria parasites
Bằng: Knuepfer, E, et al.
Được phát hành: (2019)